ArticleFrontiers in molecular biosciences2022

Utility of a Recombinant HSV-1 Vaccine Vector for Personalized Cancer Vaccines.

Ifeanyi Kingsley Uche et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.